Try our Advanced Search for more refined results
Insys Therapeutics, Inc.
Case Number:
1:19-bk-11292
Court:
Nature of Suit:
Firms
- Akin Gump
- ASK LLP
- Barrett Law Group
- Benesch
- Berger Harris
- Bielli & Klauder
- Blank Rome
- Bonville & Howard
- Brown Rudnick
- Buchanan Ingersoll
- Chamberlain Hrdlicka
- Chiesa Shahinian
- Chipman Brown
- Cole Schotz
- Connolly Gallagher
- Consovoy McCarthy
- Cross & Simon
- Duane Morris
- Eckert Seamans
- Faegre Drinker
- Ferry Joseph
- Gilbert LLP
- Hagens Berman
- Halperin Battaglia
- Hogan McDaniel
- Holland & Knight
- Howard & Howard
- Hughes Hubbard
- Hutchison & Steffen
- Keller Postman
- Klehr Harrison
- KP Law Limited
- Landis Rath
- Lowenstein Sandler
- Mayer Brown
- May Potenza
- McCarter & English
- McDermott Will & Emery
- Montgomery McCracken
- Morris Nichols
- Orlans PC
- Pachulski Stang
- Patterson Belknap
- Pillsbury Winthrop
- Potter Anderson
- Reid Collins
- Richards Layton
- Robins Kaplan
- Rosner Law Group LLC
- Seward & Kissel
- Shipman & Goodwin
- Sills Cummis
- Skadden Arps
- Stevens & Lee
- Stoel Rives
- Sullivan Hazeltine
- Theodora Oringher
- Wagstaff & Cartmell
- Weil Gotshal
- Whiteford Taylor
- Wilson Sonsini
- Womble Bond
- Young Conaway
Companies
- Bessemer Group Inc.
- Cardinal Health Inc.
- Cencora Inc.
- Covance Inc.
- Ernst & Young LLP
- FTI Consulting Inc.
- H.D. Smith LLC
- Iron Mountain Inc.
- Ironshore Inc.
- Johnson & Johnson
- Lazard Ltd.
- McKesson Corp.
- Pioneer Telephone Cooperative Inc.
- Receptor Life Sciences
- Salt River Project
- The Children's Hospital of Philadelphia
- The Cigna Group
- Toyota Motor Corp.
Government Agencies
- California Department of Health Care Services
- Commonwealth of Kentucky
- Missouri Department of Revenue
- New York State Department of Health
- Pennsylvania Department of Human Services
- State of Indiana
- State of Maryland
- State of Michigan
- State of Nevada
- Texas Comptroller of Public Accounts
Sectors & Industries:
-
August 01, 2024
Insys Trust Sees $6M Clawback For Ex-CEO's Defense Upheld
A Delaware federal judge has ruled a liquidating trust for drugmaker Insys Therapeutics can claw back $6 million paid out for the criminal defense of ex-CEO John Kapoor, affirming a bankruptcy court's ruling last year.
-
January 23, 2024
Ex-CEO's Counterclaims Not Allowed, Insys Trustee Says
The liquidation trustee of Insys Therapeutics on Tuesday asked a Delaware bankruptcy judge for an injunction preventing the pharmaceutical company's former CEO Michael L. Babich from pursuing counterclaims in a clawback suit from the trustee in Delaware's Chancery Court.
-
August 17, 2023
Judge Says Ex-Insys CEO Has To Repay $6M In Defense Fees
A Delaware bankruptcy judge Thursday found the liquidating trustee for drugmaker Insys Therapeutics can claw back $6 million it paid for the criminal defense of ex-CEO John Kapoor, saying Kapoor can't claim his defense was successful after serving prison time for the charges.
-
June 07, 2023
Ex-Insys CEO Says Legal Fee Clawback Unsupported In Ch. 11
The former CEO of drugmaker Insys Therapeutics told a Delaware bankruptcy judge Wednesday that he shouldn't have to return $6 million in legal fees the company advanced to him for criminal defense costs because he was partially successful in his defense, despite a conviction that came with jail time.
-
April 07, 2023
Insys Ch. 11 Trustee Slams Kapoor's Legal Fee Clawback Bid
A bankruptcy trustee for Insys Therapeutics has urged a Delaware judge to order imprisoned former company CEO John Kapoor to return nearly $6 million paid by Insys for his felony racketeering defense, arguing that Kapoor wrongly claimed that some cash went to dropped actions or civil matters.
-
January 16, 2020
Insys Wins OK For Ch. 11 Plan With Opioid Recovery Trust
Bankrupt drugmaker Insys Therapeutics Inc. secured confirmation in Delaware on Thursday for a Chapter 11 liquidation and recovery trust that could initially make $160 million available for victims of an opioid epidemic whose potential claims could climb into the billions.
-
January 09, 2020
Chubb Says Insys Ch. 11 Plan Unclear On Insurance Terms
A number of Chubb Group companies Thursday filed an objection to pain medication maker Insys Therapeutics Inc.'s Chapter 11 plan, saying it would create confusion about how their policy obligations would be treated.
-
January 06, 2020
SEC Says Insys 3rd-Party Releases Should Be Opt-In
The U.S. Securities and Exchange Commission on Monday urged the Delaware bankruptcy court to reject the third-party liability releases in pain medication maker Insys Therapeutics Inc.'s Chapter 11 plan, saying the releases need the OK of shareholders and others.
-
December 02, 2019
Insys Files New Ch. 11 Plan Reflecting Deal With DOJ, States
Bankrupt opioid maker Insys Therapeutics Inc. filed an amended Chapter 11 plan Friday in Delaware that reflects the negotiated agreement reached among the debtor and its creditors, including the U.S. Department of Justice and numerous states, municipalities and Native American tribes.
-
November 21, 2019
Insys Reaches Creditor Deal For Tiered Ch. 11 Recoveries
Bankrupt opioid maker Insys Therapeutics Inc. told a Delaware bankruptcy judge Thursday that negotiations over the past week had resulted in a deal with its creditors on a Chapter 11 plan that will provide tiered recoveries to claimants in different classes.